SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011781
Filing Date
2018-05-08
Accepted
2018-05-08 16:02:19
Documents
66
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q scyx-10q_20180331.htm 10-Q 1201217
2 EX-10.1 scyx-ex101_169.htm EX-10.1 16122
3 EX-10.2 scyx-ex102_15.htm EX-10.2 31090
4 EX-31.1 scyx-ex311_10.htm EX-31.1 15623
5 EX-31.2 scyx-ex312_8.htm EX-31.2 16082
6 EX-32.1 scyx-ex321_9.htm EX-32.1 9410
  Complete submission text file 0001564590-18-011781.txt   5965191

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT scyx-20180331.xml EX-101.INS 1355580
8 XBRL TAXONOMY EXTENSION SCHEMA scyx-20180331.xsd EX-101.SCH 46457
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scyx-20180331_cal.xml EX-101.CAL 45866
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scyx-20180331_def.xml EX-101.DEF 165570
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20180331_lab.xml EX-101.LAB 371937
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20180331_pre.xml EX-101.PRE 311519
Mailing Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548
Business Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 18814456
SIC: 2834 Pharmaceutical Preparations